AlphaHunt
Healthcare

RMD Stock Analysis

ResMed Inc. · current price $186.49 (-3.84% today)

★★ Below Avg 47/ Alpha Score
Risk is rising; momentum is fading or fundamentals are weakening. Multiple risk indicators are firing.
LAST EARNINGS ResMed Inc. (RMD)

Latest earnings

EPS
$2.55 vs $2.48 est · +0.0% vs estimate BEAT
Revenue
$1.43B · +6.2% YoY
Stock reaction (1M)
-8.8%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
47/100
Grade
D
Rev Growth YoY
+10.8%
30-day Momentum
-8.8%
Forward P/E
17.9×
Analyst Target
$265.93
Implied Upside
+42.6%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

RMD — frequently asked

What is RMD's Alpha Score?

ResMed Inc. (RMD) currently has a TickerMover Alpha Score of 47/100, rated ★★ Below Avg. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is ResMed Inc. (RMD) a buy?

TickerMover does not give buy or sell recommendations. RMD scores 47/100 (★★ Below Avg) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is RMD's score updated?

RMD's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for RMD →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com